Dr. Iris Schmitt Email & Phone Number

Expert in PBMC isolation and training: Several years of international experience in training of lab staff for clinical studies and auditation (GCLP)• Development of preclinical & clinical research programs# project management (planning & coordination & monitoring) developing and directing of preclinical research programs - project management investigator initiated triale (IIT), Regulatory Affairs scientific writing, review of scientific reports and data analysis IND/CTA document archiving according to eCTD  supporting QA unit (GLP/GCP, SOPs, audits, Site-Master File)Scientific Marketing- Content Management in Joomla and Shop Ware- Product Informations, MSDS, CoAs, Handbooks etc. • Project manager in major customer projects responsible for the development and validation of cellular assays for screening and hit profiling using cell lines and primary neurons  coordination and supervision of screening activities, data analysis and reporting responsible for hit selection, quality and data communication with customers• High content screening (HCS) platform responsible for implementing novel high content screening platform using the proprietary Evotec OperaTM to enlarge company portfolio (cell cycle, apoptosis, cytotoxicity profiling, signal transduction) scientific advisor & assay developer for customer high content screening programs supervision of successful phenotypcial cancer screening programScientific Skills• R&D and target validation strong scientific background and hands on experience in molecular biology and cell biology (cell based assays, viral expression systems, cultivation of mammalian cell lines, isolation and propagation of primary cells (PBMCs and neurons), transfection methods, confocal microscopy, cloning and protein purification/characterization, ELISA) industrial experience in validation of novel diabetes drug targets  knowledge & laboratory experience in various disease areas (virology, oncology, diabetes and neurodegenerative diseases)

Listed skills include Biotechnology, Lifesciences, Assay Development, Pharmaceutical Industry, and 8 others.